We are pleased to announce our investment in Por Med Tech Inc., a Meiji University-based startup dedicated to providing genetically modified donor pigs for human organ transplantation.

As part of this collaboration, we will be involved in the construction of production facilities for donor pigs, as well as research and development infrastructure to support this groundbreaking initiative.

For further details, please refer to the press release linked below.

Sekine Corporation Press Release – Entry into Xenotransplantation Business (February 5, 2025)